Universal Technical Institute (UTI) is rated Buy, trading at 1.17 times its 2027 estimated sales. The recent cut in revenue guidance is attributed mainly to staffing problems in the high school channel rather than a drop in demand, as strong inquiry growth supports this. New campus openings in San Antonio and Atlanta are performing better than expected, which should help sustain enrollment and revenue growth through 2027. The analyst will reconsider the rating if UTI's growth falls below 5% in Q1 2027 or if revenue guidance drops below $950 million, indicating unresolved issues in the enrollment funnel.
Marshall Tucker, CFO of Smucker, sold 18,482 shares of the company, generating $2.4 million from the sale. This insider transaction may indicate personal financial planning or a shift in confidence, which investors often watch closely. The sale's imp...
Filament Health, a subsidiary of Rhelion Life Sciences, has completed another delivery of its patented psilocybin drug candidate PEX010 to Germany's Central Institute of Mental Health. This supports Germany's pioneering compassionate use program for ...
Deutsche Bank upgraded Dunelm Group PLC to a 'buy' rating, expecting accelerated earnings growth driven by a new strategy presentation. The retailer plans to enhance its digital offerings and increase store investments to capture a larger market shar...
Broadcom projects its AI semiconductor revenue will jump from $58 billion in fiscal 2026 to about $230 billion by fiscal 2028, signaling rapid growth in AI infrastructure demand. In Q3, AI-related revenue surged 221% to $16.7 billion, with a strong o...
Hargreaves Lansdown, the UK's largest retail investment platform, plans to offer physically backed Bitcoin and Ethereum exchange-traded notes (ETNs) following the Financial Conduct Authority's lifting of a four-year ban on retail crypto ETNs. Despite...
